Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $43.1600 (-4.26%) ($43.0500 - $44.6500) on Thu. May. 19, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.13% (three month average) | RSI | 46 | Latest Price | $43.1600(-4.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -1.1% a day on average for past five trading days. | Weekly Trend | BAX declines -0.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(51%) VYM(51%) SPY(50%) IVE(49%) | Factors Impacting BAX price | BAX will decline at least -0.565% in a week (0% probabilities). VIXM(-18%) TLT(-17%) UUP(-7%) GDXJ(-7%) IPO(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.565% (StdDev 1.13%) | Hourly BBV | 0 () | Intraday Trend | -2.7% | | | |
|
Resistance Level | $44.76 | 5 Day Moving Average | $44.77(-3.6%) | 10 Day Moving Average | $45.13(-4.37%) | 20 Day Moving Average | $44.76(-3.57%) | To recent high | -7% | To recent low | 14.6% | Market Cap | $22.019b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |